no key · no human
Trends › Canada › story

Medical and pharmaceutical developments

health A story tracked across 3 publishers in Canada, the whole story.

27
articles
3
publishers
Sep 23 18:01
first seen
Oct 21 09:30
last seen

Coverage over time

2026-09-23 18:01 UTC — 32026-09-24 07:50 UTC — 12026-09-24 21:39 UTC — 02026-09-25 11:29 UTC — 12026-09-26 01:18 UTC — 02026-09-26 15:07 UTC — 02026-09-27 04:57 UTC — 02026-09-27 18:46 UTC — 02026-09-28 08:36 UTC — 42026-09-28 22:25 UTC — 12026-09-29 12:14 UTC — 02026-09-30 02:04 UTC — 02026-09-30 15:53 UTC — 02026-10-01 05:42 UTC — 32026-10-01 19:32 UTC — 02026-10-02 09:21 UTC — 02026-10-02 23:11 UTC — 02026-10-03 13:00 UTC — 02026-10-04 02:49 UTC — 02026-10-04 16:39 UTC — 02026-10-05 06:28 UTC — 12026-10-05 20:17 UTC — 02026-10-06 10:07 UTC — 12026-10-06 23:56 UTC — 12026-10-07 13:46 UTC — 12026-10-08 03:35 UTC — 22026-10-08 17:24 UTC — 22026-10-09 07:14 UTC — 02026-10-09 21:03 UTC — 02026-10-10 10:52 UTC — 02026-10-11 00:42 UTC — 02026-10-11 14:31 UTC — 02026-10-12 04:21 UTC — 02026-10-12 18:10 UTC — 02026-10-13 07:59 UTC — 02026-10-13 21:49 UTC — 02026-10-14 11:38 UTC — 12026-10-15 01:27 UTC — 02026-10-15 15:17 UTC — 02026-10-16 05:06 UTC — 42026-10-16 18:56 UTC — 02026-10-17 08:45 UTC — 02026-10-17 22:34 UTC — 02026-10-18 12:24 UTC — 02026-10-19 02:13 UTC — 02026-10-19 16:02 UTC — 02026-10-20 05:52 UTC — 02026-10-20 19:41 UTC — 12026-10-21 09:31 UTC — 009-2309-2709-3010-0410-0710-1110-1410-1710-21

Who covered it

PublisherArticles
investingnews.com15
www.newswire.ca9
financialpost.com3

Articles

When (UTC)HeadlinePublisher
10-21 09:30ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasivinvestingnews.com
10-16 18:05Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopiainvestingnews.com
10-16 16:05Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopiawww.newswire.ca
10-16 14:00AHN Cancer Center Launches RANDY'S Trial, Funded by Community Support and Inspired by a Firefighter's Legacywww.newswire.ca
10-16 09:00Libtayo® Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Typesinvestingnews.com
10-14 18:18FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Diseaseinvestingnews.com
10-09 03:00FDA Approves Genentech's Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Coinvestingnews.com
10-08 18:12Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca's ETCAMAH in Advanced ER-positive Breast Cancinvestingnews.com
10-08 15:20Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USPfinancialpost.com
10-08 15:16Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USPwww.newswire.ca
10-07 14:57Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancerinvestingnews.com
10-07 10:30RenovoRx Advances TAMP into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trialinvestingnews.com
10-06 16:05Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemwww.newswire.ca
10-05 10:00Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE Plus Zoldonrasib as First-Line Treatment for Metastatiinvestingnews.com
10-01 11:00Novocure's Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancerinvestingnews.com
10-01 08:09ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Canwww.newswire.ca
10-01 08:09ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Canwww.newswire.ca
09-29 09:01BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUinvestingnews.com
09-28 16:01Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)financialpost.com
09-28 09:15Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspensionfinancialpost.com
09-28 09:09Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspensionwww.newswire.ca
09-28 08:58DRI Healthcare Comments on Juvmo's (tavapadon) FDA Approvalwww.newswire.ca
09-25 21:00Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressivainvestingnews.com
09-24 09:00Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Productinvestingnews.com
09-23 20:17FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Testinvestingnews.com
09-23 18:17FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Testwww.newswire.ca
09-23 18:01Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Towardinvestingnews.com

Get this as JSON

bash
curl -s "https://freenewsapi.ai/v1/trends/CA/medical-and-pharmaceutical-developments"